These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1716380)

  • 1. Nonradical excited oxygen species induce selective thrombolysis in vivo.
    Stief TW
    Thromb Res; 1991 May; 62(3):147-63. PubMed ID: 1716380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase.
    Stief TW; Stief MH; Ehrenthal W; Darius H; Martin E
    Thromb Res; 1991 Dec; 64(5):597-610. PubMed ID: 1808764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring activity of fibrinolytic agents. A therapeutic challenge.
    Shafer KE; Santoro SA; Sobel BE; Jaffe AS
    Am J Med; 1984 May; 76(5):879-86. PubMed ID: 6232847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel chimaeric derivative of saruplase, rscu-PA-40 kDA/Hir, binds to thrombin and exerts thrombus-specific fibrinolysis in arterial and venous thrombosis in dogs.
    Schneider J; Hauser R; Hennies HH; Korioth J; Steffens G; Wnendt S
    Thromb Haemost; 1997 Mar; 77(3):535-9. PubMed ID: 9066007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinolytic system in man.
    Collen D; Lijnen HR
    Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antithrombotic factor singlet oxygen/light (1O2/h nu).
    Stief TW; Fareed J
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):22-30. PubMed ID: 10726045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo].
    Bode C; Eberle T; Runge M; Haber E; Kübler W
    Verh Dtsch Ges Inn Med; 1990; 96():1-3. PubMed ID: 2128723
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolytic effect of single-chain pro-urokinase in a rabbit jugular vein thrombosis model.
    Matsuo O; Bando H; Okada K; Tanaka K; Tsukada M; Iga Y; Arimura H
    Thromb Res; 1986 Apr; 42(2):187-94. PubMed ID: 3087008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis.
    Collen D; Stassen JM; Blaber M; Winkler M; Verstraete M
    Thromb Haemost; 1984 Aug; 52(1):27-30. PubMed ID: 6541817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Singlet oxygen enhances intrinsic thrombolysis: the intrinsic oxidative clot lysis assay (INOXCLA).
    Stief TW
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):369-83. PubMed ID: 17911188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant single-chain urokinase-type plasminogen activator (rscu-PA) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis.
    Söhngen W; Mickelson JK; Simpson PJ; Lucchesi BR
    Thromb Res; 1988 Jul; 51(1):63-74. PubMed ID: 3137691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitors.
    Sidelmann J; Jespersen J; Kluft C; Gram J
    Clin Chim Acta; 1997 May; 261(1):43-56. PubMed ID: 9187504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic effects of pro-urokinase combined with low-dose urokinase compared to high-dose urokinase in patients with acute myocardial infarction.
    Pindur G; Koehler M; Sen S; Hermes R; Miyashita C; Wenzel E; Schieffer H
    Thromb Res; 1992 Jul; 67(2):191-200. PubMed ID: 1279835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of epithelial tissue plasminogen activator as a thrombolytic agent in a rabbit model of venous thrombosis.
    Electricwala A; Emeis JJ; Atkinson T
    J Pharmacol Exp Ther; 1986 Jul; 238(1):254-8. PubMed ID: 2425075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.
    Collen D; Stump D; van de Werf F; Jang IK; Nobuhara M; Lijnen HR
    Circulation; 1985 Aug; 72(2):384-8. PubMed ID: 3924437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.